We have shown that macrophages in the GBM microenvironment express higher levels of ALDH1A2 and that RA modulates MMP-2 and MMP-9 expression and activity; this could lead to downstream modulation of tumor invasiveness and progression in a local fashion and may explain the lack of therapeutic benefit of RA. The gene discussed is ALDH1A2; the disease is neoplasm.